Blockade of constitutively activated Janus kinase/signal transducer and activator of transcription-3 pathway inhibits growth of human pancreatic cancer
- 1 November 2003
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 201 (1) , 107-116
- https://doi.org/10.1016/s0304-3835(03)00482-8
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Requirement of Stat3 signaling for HGF/SF-Met mediated tumorigenesisOncogene, 2002
- Gemcitabine following radiotherapy with concurrent 5‐fluorouracil for nonmetastatic adenocarcinoma of the pancreasInternational Journal of Cancer, 2001
- Novel clinical strategies for the treatment of pancreatic carcinomaTrends in Molecular Medicine, 2001
- The role of STATs in transcriptional control and their impact on cellular functionOncogene, 2000
- Pancreatic cancerCurrent Problems in Surgery, 1999
- Chemotherapy in the treatment of cancer of the pancreas.Journal of Hepato-Biliary-Pancreatic Surgery, 1998
- Low mortality following resection for pancreatic and periampullary tumours in 1026 patients: UK survey of specialist pancreatic unitsBritish Journal of Surgery, 1997
- Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.Journal of Clinical Oncology, 1997
- Population-based analysis of treatment of pancreatic cancer and Whipple resection: Department of Defense hospitals, 1989–1994Surgery, 1996
- The national cancer data base report on pancreatic cancerCancer, 1995